Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 6.75 6.50 7.00 6.75 6.75 6.75 127,449 07:46:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18.3 -12.0 -1.8 - 49

Yourgene Health Share Discussion Threads

Showing 4626 to 4646 of 4650 messages
Chat Pages: 186  185  184  183  182  181  180  179  178  177  176  175  Older
DateSubjectAuthorDiscuss
22/6/2022
17:52
Be careful..... phatomtrader is just making stuff up about sales. He will never evidence it as untrue.
twix386
22/6/2022
17:19
what strategy was that then? You seem to assume an awful lot phatom! Keep saying all have sold their shares..prove it, or shut up about it! No, Bill Chang hasn't sold any shares
hjb1
22/6/2022
17:06
what is it with you? 99% of your posting is about Ygen, and it's all derogatory.. Something really gets under your skin doesn't it.. Quite comical tbf!
hjb1
22/6/2022
17:01
yes it's doing about as well as your tip (GDR)in March last year...ooops!,Hope you didn't put any money in? Down around 80% isn't it..lol Perhaps it's just what Ygen need to get rid of the deadwood at the top!
hjb1
22/6/2022
15:57
I thought the reason why AR chose Vialogy as the 'shell' target for a reverse take-over was that his Dad was a Vialogy shareholder and lost a packet. With both him and Nicky boy now selling out the original group that made up the Management Board (such as Stuart Lawson and Rupert Lywood) have now left. Would be interesting to know whether Bill Chang (or the shares he gave his wife) have also been sold down. LR should just put old shareholders out of misery now and just put the "For Sale" sign out now. With AR and Nick boy's departure this is unlikely, however would reflect that the strategy has officially failed. LR gives a good speech, but the reality is that the volume here is non-existent and number of trades barely breaking into double digits. Over on the LSE BB the majority of the discussions come from Posters sending posts to their aliases to make it seem there is more interest than there is. Perhaps these Posters should also sell and buy their 'ghost' millions of shares between their aliases to pump the volume?
phatomtraider
21/6/2022
23:10
one lab signed up just on the better accuracy alone. They never even knew about the massive cost savings at the time. Some will say it has luckily fallen into their laps..who cares I say!
hjb1
21/6/2022
23:00
I agree, this Ranger tech looks the biz.Far better results and the cost savings will swing it.Labs just can't afford not look at it and use it.I think the real money spinner is it's use for oncology too.I expect more partners being signed in the coming weeks and months
birdie12
21/6/2022
22:49
For anyone who hasn't viewed. Click on the links. it's good stuff! 'disruptive and a revolution' apparently! lol hTTps://www.yourgene-health.com/about/the-y-series/your-comment/87-the-y-series/your-comment/1933-ranger-revolution-lightbench-detect-is-here-20-june-2022
hjb1
21/6/2022
22:16
How's your GDR tip going from March 2021...oooh! not so good I see. What was it around then, about 90/100p?
hjb1
21/6/2022
21:51
I think there will be plenty of good news well before year end. You never know, this Ranger tech could be very good. At least it's got good accreditation from independents like Laval Uni, and not LR bull.
hjb1
21/6/2022
20:22
AR hasn't sold his shares pal! Stop lying, unless you have proof!
hjb1
21/6/2022
18:51
looks like drop into 6p range is inevitable here. Sad to see, hope past warnings were adhered to by some. Sp will have to more than double to get back to when LR took over as CEO. Difficult to see much change before end of year, hence why AR and Nicky boy sold their shares and left the BoD.
phatomtraider
23/5/2022
17:48
A good start to the week
lancasterbomber
12/5/2022
14:34
Anyone interested needs to see the CMD presentation, especially Scott Sargent who is the VP of sales in the US. Very able person who knows what he is doing.
hjb1
12/5/2022
14:29
10 x last year revenues will do for any buyout. If as expected Ranger starts to take market share away from Illumina/others then people will take it more seriously! Hopefully two of the four megalabs will be onboard shortly too! Ranger has better quality and accuracy than anything else on the market, inc Illumina. Just look at the cost savings on blood tubes, some 90% saving on every test taken...just in tubes alone. Why would a lab pay $20 when they can pay $1 or $2
hjb1
12/5/2022
13:11
Thanks hjb1 - sorry about the 'Alumina' I hope it was a spell checker 😊 I particularly like your information about the history, it adds weight. I once wrote a case study about a patent extension that was clearly technically idiotic - but it was filed as a business protection tactic. YGEN is such a minnow that it might be easier to buy the company than fight the patent. apad
apad
12/5/2022
11:58
apad, as far as I can see, Ranger is in three parts protected and was first filed in June 2014, then Jan/Feb 2015 for other parts. Patents granted in 2019/2020..
hjb1
12/5/2022
11:43
Ranger is patent protected I believe, and yes, there will always be competition in massive markets like this. Ranger is very disruptive to Illumina, amongst others!
hjb1
12/5/2022
11:13
Can anyone help with this? I may well have got confused! I did not see a clear statement that they had dropped Allumina but there seems to be a clear issue between conventional NIPT through Allumina and Ranger. The nub of the issue seems to be whether, say, Alumina, or someone else, develops a similar process. IP has no real value until it is protected and YGEN can't afford a fight. LR is a deal maker, so I guess the measure of progress is Ranger Roll Out. apad
apad
12/5/2022
08:55
Yea right, the fact that the share price fell to 7.10p was just due to disaffected PIs. Funny coincidence that the CEO bought 1m shares below the market price. Guess it was mates rates. We'll see if this also indicates a quiet news period as no material news can now be immediately issued. At least these are real share purchases and not the carp you see day-in, and day-out on apparent LTH purchases. If you filtered on the Tarzan character purchases, he's bought more than the CEO this year alone, and he's not the only one.
phatomtraider
12/5/2022
08:34
Unless you have some proof do be quiet.
birdie12
Chat Pages: 186  185  184  183  182  181  180  179  178  177  176  175  Older
ADVFN Advertorial
Your Recent History
LSE
YGEN
Yourgene H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220629 18:43:07